Drug Supply Alert: Emerging Adulterants to Watch for Summer 2026
Several new adulterants were detected in North American and European drug markets in the first half of 2026. Medetomidine, new nitazene analogs, and xylazine spreading to Europe. What to test for and how.
1. Medetomidine: The New Tranq
A veterinary sedative more potent than xylazine, detected in Western US, parts of Canada, and sporadically in the UK since late 2025. Causes profound sedation not reversed by naloxone. Requires dedicated medetomidine test strips ($15/10pk).
2. Nitazene Proliferation
Confirmed in 35+ US states, Canada, UK, and EU. New analogs include protonitazene and etodesnitazene. Standard fentanyl strips do NOT detect nitazenes. Use BTNX dual strips or standalone nitazene strips.
3. Xylazine Reaches Europe
Detected in UK (London, Manchester, Glasgow) and Netherlands. Causes necrotic wounds. Not reversed by naloxone. Test every batch with xylazine strips ($15/10pk).
4. New Benzo Analogs
Bromazolam (most common in counterfeit Xanax), flubromazepam (200-hour half-life), desalkylgidazepam. Zimmermann reagent for class confirmation.
Regional Priorities
Northeastern US: Fentanyl + nitazenes, xylazine. Western US: Medetomidine. Canada: Full panel. UK: Nitazenes, bromazolam. EU: Nitazenes, novel benzos.
Updated July 29, 2026. Data from drug checking services and public health surveillance.
Ready to Test Safely?
All reagents, test strips, and testing accessories mentioned in this guide are available in our catalog — shipped discreetly worldwide.